A coagulation factor moonlights in the heart

Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease

(2022) Alessandro Mantovani et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

BMP7-based peptide agonists of BMPR1A protect the left ventricle against pathological remodeling induced by pressure overload

(2022) Ana B. Salido-Medina et al.   BIOMEDICINE & PHARMACOTHERAPY

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

(2022) Jonathan P Piccini et al.   LANCET

Cellular and molecular pathobiology of heart failure with preserved ejection fraction

(2021) Sumita Mishra et al.   Nature Reviews Cardiology

Hepatokines as a Molecular Transducer of Exercise

(2021) Dae Yun Seo et al.   Journal of Clinical Medicine

Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries

(2021) Marat Fudim et al.   Journal of the American Heart Association

Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic Cardiomyopathy

(2021) Mitchel Tate et al.   Frontiers in Pharmacology

Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction

(2021) Husam M. Salah et al.   JACC-Basic to Translational Science

Nitrosative stress drives heart failure with preserved ejection fraction

(2019) Gabriele G. Schiattarella et al.   NATURE

Factor XI as a Therapeutic TargetHighlights

(2016) David Gailani et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation

(2016) Dipak Kotecha et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Hepatokines as a Link between Obesity and Cardiovascular Diseases

(2015) Hye Jin Yoo et al.   Diabetes & Metabolism Journal

Interactions of the heart and the liver

(2013) Søren Møller et al.   EUROPEAN HEART JOURNAL